HARBURY PHARMACY LIMITED

Company Registration Number:
08130314 (England and Wales)

Unaudited abridged accounts for the year ended 31 July 2023

Period of accounts

Start date: 01 August 2022

End date: 31 July 2023

HARBURY PHARMACY LIMITED

Contents of the Financial Statements

for the Period Ended 31 July 2023

Balance sheet
Notes

HARBURY PHARMACY LIMITED

Balance sheet

As at 31 July 2023


Notes

2023

2022


£

£
Called up share capital not paid: 0 0
Fixed assets
Intangible assets: 3 2,914 11,661
Tangible assets: 4 1,780 2,094
Total fixed assets: 4,694 13,755
Current assets
Stocks: 27,693 23,525
Debtors:   55,071 48,632
Cash at bank and in hand: 223,447 226,623
Total current assets: 306,211 298,780
Creditors: amounts falling due within one year:   (110,941) (107,187)
Net current assets (liabilities): 195,270 191,593
Total assets less current liabilities: 199,964 205,348
Provision for liabilities: (637) (637)
Total net assets (liabilities): 199,327 204,711
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 199,227 204,611
Shareholders funds: 199,327 204,711

The notes form part of these financial statements

HARBURY PHARMACY LIMITED

Balance sheet statements

For the year ending 31 July 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 20 February 2024
and signed on behalf of the board by:

Name: SURESH PATEL
Status: Director

The notes form part of these financial statements

HARBURY PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2023

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

HARBURY PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2023

2. Employees

2023 2022
Average number of employees during the period 6 6

HARBURY PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2023

3. Intangible Assets

Total
Cost £
At 01 August 2022 350,000
At 31 July 2023 350,000
Amortisation
At 01 August 2022 338,339
Charge for year 8,747
At 31 July 2023 347,086
Net book value
At 31 July 2023 2,914
At 31 July 2022 11,661

HARBURY PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 July 2023

4. Tangible Assets

Total
Cost £
At 01 August 2022 10,701
At 31 July 2023 10,701
Depreciation
At 01 August 2022 8,607
Charge for year 314
At 31 July 2023 8,921
Net book value
At 31 July 2023 1,780
At 31 July 2022 2,094